Social network
Investors - Ensuring sustainable growth
Investors - Ensuring sustainable growth

Investors

Ensuring sustainable growth

Tools content (print, share, increase/decrease text size):

 

IR Thematic call on dupilumab

October 01, 2016

Sanofi and Regeneron hosted a conference call for the financial community focusing on investigational dupilumab following the late breaking data presentation from two trials evaluating dupilumab for inadequately controlled moderate-to-severe atopic dermatitis (SOLO 1 and SOLO 2) at the 25th European Academy of Dermatology and Venereology (EADV) Congress in Vienna, Austria.

 

The presentation was followed by a Q&A session.

 

Replay numbers:

1 (888) 843-7419
1 (630) 652-3042

Passcode: 4348 2242#

 

Related Press releases

 

Right area:

Stock Market

IR mobile application

SANOFI IR - The Investor Relations Mobile Application

SANOFI IR is available on iPhone, iPad, Apple Watch and Android!
NEW - Section dedicated to Individual Shareholders

 

Your services

 

© Sanofi 2004-2017 - All rights reserved - Update: November 29, 2016

  • Site complies with W3C WCAG 2.0 (new window, in english)